DK0764405T3 - Ernæringspræparat - Google Patents

Ernæringspræparat

Info

Publication number
DK0764405T3
DK0764405T3 DK96202637T DK96202637T DK0764405T3 DK 0764405 T3 DK0764405 T3 DK 0764405T3 DK 96202637 T DK96202637 T DK 96202637T DK 96202637 T DK96202637 T DK 96202637T DK 0764405 T3 DK0764405 T3 DK 0764405T3
Authority
DK
Denmark
Prior art keywords
source
present
omega
fatty acids
intensive care
Prior art date
Application number
DK96202637T
Other languages
Danish (da)
English (en)
Inventor
David A Mark
Nancy Schmelkin
Diana Twyman
John Alexander
Debora Gray
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0764405T3 publication Critical patent/DK0764405T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/13Burn treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96202637T 1995-09-20 1996-09-20 Ernæringspræparat DK0764405T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/530,877 US5714472A (en) 1993-12-23 1995-09-20 Enternal formulation designed for optimized nutrient absorption and wound healing

Publications (1)

Publication Number Publication Date
DK0764405T3 true DK0764405T3 (da) 2003-02-10

Family

ID=24115344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96202637T DK0764405T3 (da) 1995-09-20 1996-09-20 Ernæringspræparat

Country Status (7)

Country Link
US (1) US5714472A (es)
EP (1) EP0764405B1 (es)
AT (1) ATE227520T1 (es)
DE (1) DE69624768T2 (es)
DK (1) DK0764405T3 (es)
ES (1) ES2185744T3 (es)
PT (1) PT764405E (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019601A1 (en) * 1995-11-24 1997-06-05 Loders Croklaan B.V. Composition based on fish oil
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US7001618B1 (en) * 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
KR100441851B1 (ko) * 2001-06-04 2004-07-27 안강호 코로나 방전을 이용한 입자의 제조장치 및 그 제조방법
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US20030104033A1 (en) * 2001-07-13 2003-06-05 Lai Chon-Si Enteral formulations
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
CN100448453C (zh) * 2003-05-22 2009-01-07 努特里奇亚有限公司 治疗或预防慢性创伤的方法及其中所使用的包含甘氨酸和/或亮氨酸的全营养组合物
EP1543735B1 (en) * 2003-12-20 2015-10-07 Nestec S.A. Nutritional composition for wound healing
EP1732577B1 (en) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topical delivery of l-arginine to improve body and skin appearance
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ, エルエルシー 局所的血流増大の有益な効果
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9179702B2 (en) 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
PT1981358E (pt) * 2006-01-31 2010-08-24 Nestec Sa Composição nutricional para bebés com baixo peso após o nascimento
FR2918543A1 (fr) * 2007-07-09 2009-01-16 Routinsa Sa Compositions alimentaires enrichies en acides insatures a base de graines d'oleagineux.
CN101820754A (zh) * 2007-10-04 2010-09-01 雀巢产品技术援助有限公司 用于增强认知功能的组合物与方法
AU2010247469B2 (en) * 2009-05-11 2014-12-18 Société des Produits Nestlé S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010149759A1 (en) 2009-06-24 2010-12-29 Basf Se Microparticles comprising a fat soluble fraction comprising dha and their production
WO2011066175A1 (en) * 2009-11-25 2011-06-03 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
BR112013019677B1 (pt) 2011-02-02 2019-10-08 Société des Produits Nestlé S.A. Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3
WO2012138212A1 (en) * 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
WO2017134256A1 (en) * 2016-02-03 2017-08-10 Fresenius Kabi Deutschland Gmbh High caloric, high protein nutritional formula
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compounds for the treatment of liver disease
US10743574B2 (en) * 2018-06-18 2020-08-18 Orgalife Nutrition Science Company Limited Oral/enteral nutritious foods and method of manufacturing the same
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
DE102018124227A1 (de) 2018-10-01 2020-04-02 sanaFactur GmbH Zubereitung zur Verbesserung körpereigener Wundheilung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients

Also Published As

Publication number Publication date
EP0764405A2 (en) 1997-03-26
EP0764405A3 (en) 1998-04-29
DE69624768T2 (de) 2003-10-02
DE69624768D1 (de) 2002-12-19
PT764405E (pt) 2003-03-31
EP0764405B1 (en) 2002-11-13
ES2185744T3 (es) 2003-05-01
US5714472A (en) 1998-02-03
ATE227520T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
DK0764405T3 (da) Ernæringspræparat
US5198468A (en) Essential fatty acid composition
DE69506642D1 (de) Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
IE891819L (en) Essential fatty acid compositions
PT780124E (pt) Composicoes farmaceuticas compreendendo uma alcanoil-l-carnitina em combinacao com acidos gordos poliinsaturados da serie omega-3 para a prevencao e o tratamento das doencas do metabolismo lipidico
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
DK0691079T3 (da) Enteral komposition til diabetespatienter
CA2104567A1 (en) Fatty acid treatment
ATE55905T1 (de) Mittel zur behandlung und zum schutz der haut.
ATE361066T1 (de) Polyungesättigen fettsäuren nährungsergänzung
CA2006136A1 (en) Randomized palm oil fat compositions for infant formulas
JPH02243623A (ja) 脂肪酸による治療および組成物
CA2231525A1 (en) Nutritional support of paediatric patients
NZ250583A (en) Pharmaceutical, nutritional, or skin care compositions containing an ester of a cholesterol and fatty acid
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
ITMI951359A0 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
DE3785667D1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE60008127D1 (de) Diät mit hohem lipidgehalt
IT1187687B (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
AU633618B2 (en) Fatty acid therapy
Campbell Clinical use of fatty acid supplements in dogs
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use